In line with this, semaglutide increases hippocampal GLP1 receptor levels in the hippocampus [75] and GLP1 analogs increase GLP1 levels in CSF and cortex in various T2D models [68, 70, 72, 77]. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.